工程化机械敏感 MSC 实现跨瘤种的合成放射诊疗靶向
Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.
FRONTIER PAPERS
Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.
Lanmodulin-Engineered Outer Membrane Vesicles for Synergistic Targeted Radio-Immunotherapy.
Targeting PPP1R14B overcomes immunotherapy resistance in prostate cancer by restoring CD8(+) T-cell infiltration via the Nrf2/CX3CL1 axis.
PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy.
Unleashing the Power of Magnetic Particle Imaging: Tailored Magnetic Nanoparticles for Ultrasensitive Detection of Bone Metastases in Prostate Cancer.
PSMA-directed CAR-T cell therapy for metastatic castration-resistant prostate cancer: a next-generation engineering perspective on stem cell-derived i
GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapy.
Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate can
Natural killer and CAR-NK cell therapies in urological cancers: Progress, mechanistic lessons from CAR-T, and future directions.
Clinically oriented immune heterogeneity in prostate cancer: emerging targets and strategies.
MEMBER ACCOUNT
登录成功会直接打开下一页。